Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Wende Hutton
AddedMar 31, 2024
UpdatedJun 28, 2026
Wende Hutton

Wende Hutton

Board Member, Altheos

Crunchbase

Wende Hutton's Career

Altheos
Altheos

South San Francisco, CA, US

Board Member· Board
Minimally Invasive Devices
Minimally Invasive Devices

Columbus, OH, US

Board Member· Board
Hyalex Orthopaedics
Hyalex Orthopaedics

Lexington, MA, US

Board Member· Board
Antiva Biosciences
Antiva Biosciences

South San Francisco, CA, US

Board Member· Board
Theraclone Sciences
Theraclone Sciences

Seattle, WA, US

Board Member· Board
Elitra Pharmaceuticals
Elitra Pharmaceuticals

San Diego, CA, US

Board Member· Board
ReVision Optics
ReVision Optics

Lake Forest, CA, US

Board Member· Board
Aldea Pharmaceuticals
Aldea Pharmaceuticals

Redwood City, CA, US

Board Member· Board
Glooko
Glooko

Palo Alto, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Wende Hutton's Career

Altheos
Altheos
Acquired$32.5M02010South San Francisco, CA, US
Board Member· Board

Leadership at Altheos

Ken KengatharanKen KengatharanCo-Founder
Rob HopfnerRob HopfnerBoard Member
Lester 'Les' KaplanLester 'Les' KaplanBoard Member
Henry H HsuHenry H HsuBoard Member
Minimally Invasive Devices
Minimally Invasive Devices
Public$47.1M332009Columbus, OH, US
Board Member· Board

Leadership at Minimally Invasive Devices

Mike HoovenMike HoovenBoard Member
Jordan S. DavisJordan S. DavisBoard Member
Fred M. SchwarzerFred M. SchwarzerBoard Member
Brent AhrensBrent AhrensBoard Member
Wayne PollWayne PollFounder
Jeff RydinJeff RydinBoard Member

Similar to Minimally Invasive Devices

Agile EndoSurgeryAgile EndoSurgeryChapel Hill, NC, USSurgical Instrumentsest. 2010Agile EndoSurgeryChapel Hill, NC, US · est. 2010

Agile EndoSurgery, based in Durham, US, develops advanced surgical tools to enhance minimally invasive surgery.

Seed · $258.7k5
Cambridge Endoscopic DevicesCambridge Endoscopic DevicesFramingham, MA, USMedical Devicesest. 2004Cambridge Endoscopic DevicesFramingham, MA, US · est. 2004

Cambridge Endoscopic Devices: Innovating hand-held laparoscopic instruments for enhanced medical procedures.

Seed · $9.1M30
EndoEvolutionEndoEvolutionRaynham, MA, USMedical Devicesest. 2009EndoEvolutionRaynham, MA, US · est. 2009

EndoEvolution LLC, a US-based medical device company, specializes in automated suturing devices for minimally invasive surgery.

Series C · $8.3M30
SanovasSanovasSan Rafael, CA, USSurgical Toolsest. 2009SanovasSan Rafael, CA, US · est. 2009

Sanovas, Inc. develops and offers minimally invasive surgical tools for complex medical procedures in the US.

Angel · $9.2M39
Hyalex Orthopaedics
Hyalex Orthopaedics
Series A$33M262016Lexington, MA, US
Board Member· Board

Leadership at Hyalex Orthopaedics

Carl VauseCarl VauseCEO
Bill HarringtonBill HarringtonBoard Member
Lampros KourtisLampros KourtisCo-Founder
Renee RyanRenee RyanBoard Member
David MyungDavid MyungCo-Founder
Antiva Biosciences
Antiva Biosciences
Series E$140.3M242012South San Francisco, CA, US
Board Member· Board

Leadership at Antiva Biosciences

Steven JamesSteven JamesBoard Member
Vinzenz PloererVinzenz PloererBoard Member
Karl HostetlerKarl HostetlerFounder
Gail MaderisGail MaderisBoard Member
Jenny YipJenny YipBoard Member
Kristine BallKristine BallBoard Member
Theraclone Sciences
Theraclone Sciences
Seed$63.2M322004Seattle, WA, US
Board Member· Board

Leadership at Theraclone Sciences

Chris MirabelliChris MirabelliBoard Member
Johnny StineJohnny StineFounder
Steve GillisSteve GillisBoard Member
Elitra Pharmaceuticals
Elitra Pharmaceuticals
Series B$22M1751997San Diego, CA, US
Board Member· Board

Leadership at Elitra Pharmaceuticals

Judith ZyskindJudith ZyskindBoard Member
J Gordon FoulkesJ Gordon FoulkesBoard Member
Dr Charles C HsuDr Charles C HsuBoard Member
ReVision Optics
ReVision Optics
Public$194.9M751996Lake Forest, CA, US
Board Member· Board

Leadership at ReVision Optics

Brian DoveyBrian DoveyBoard Member
Gil KlimanGil KlimanBoard Member
Alain SchreiberAlain SchreiberBoard Member
Hansen A. YuanHansen A. YuanFounder
Mikhail GetmanMikhail GetmanBoard Member
Frank FischerFrank FischerBoard Member
Aldea Pharmaceuticals
Aldea Pharmaceuticals
Series B$42M3752011Redwood City, CA, US
Board Member· Board

Leadership at Aldea Pharmaceuticals

Wenjin YangWenjin YangFounder

Similar to Aldea Pharmaceuticals

Amygdala NeurosciencesAmygdala NeurosciencesPalo Alto, CA, USBiopharmaceuticalsest. 2015Amygdala NeurosciencesPalo Alto, CA, US · est. 2015

Amygdala Neurosciences Inc: A California-based biopharmaceutical company.

Seed · $8.9M30
Alkeus PharmaceuticalsAlkeus PharmaceuticalsBoston, MA, USPharmaceuticals, Therapeuticsest. 2011Alkeus PharmaceuticalsBoston, MA, US · est. 2011

Alkeus Pharmaceuticals: A Boston-based startup innovating treatments for serious eye conditions.

Series B · $150.1M15
Aldeyra TherapeuticsAldeyra TherapeuticsBurlington, MA, USEye Disease Treatmentsest. 2004Aldeyra TherapeuticsBurlington, MA, US · est. 2004

Aldeyra Therapeutics develops treatments for age-related macular degeneration, aiming to prevent blindness.

Series A · $4.8M5
Alavita PharmaceuticalsAlavita PharmaceuticalsMountain View, CA, USPharmaceuticalsest. 2005Alavita PharmaceuticalsMountain View, CA, US · est. 2005

Alavita Pharmaceuticals Inc.: Innovating in drug industry to reduce organ transplant failure.

Pre-Seed · $600k5
Glooko
Glooko
Series D$201M2822010Palo Alto, CA, US
Board Member· Board

Leadership at Glooko

Chamath PalihapitiyaChamath PalihapitiyaCo-Founder
Yogen DalalYogen DalalBoard Member
Sunny MadraSunny MadraCo-Founder
Charles BooradyCharles BooradyBoard Member
Alfonso ZuluetaAlfonso ZuluetaBoard Member
Russ JohannessonRuss JohannessonBoard Member

Similar to Glooko

GlumetricsGlumetricsIrvine, CA, USGlucose Monitors, Medical Devicesest. 2005GlumetricsIrvine, CA, US · est. 2005

GluMetrics Inc.: A US-based medical device company specializing in innovative glucose monitoring solutions.

Series A · $68.2M30
DexcomDexcomSan Diego, CA, USGlucose Monitors, Medical Devicesest. 1999DexcomSan Diego, CA, US · est. 1999

Dexcom, Inc.: A San Diego-based medical device company specializing in continuous glucose monitoring systems for diabetics.

Public · $1.4B7.6k
GlucoIQGlucoIQNew York City, NY, USData Platform, Wireless Glucometerest. 2015GlucoIQNew York City, NY, US · est. 2015

GlucoIQ: Real-time wireless glucometer data platform enhancing patient engagement and health outcomes.

Seed · $20k5
Integrity ApplicationsIntegrity ApplicationsAshkelon, Southern District, ILMedical Devicesest. 2010Integrity ApplicationsAshkelon, Southern District, IL · est. 2010

GlucoTrack, Inc.: Innovating non-invasive glucose monitoring devices for diabetes care in the US and Israel.

Public · $50.7M5

Wende Hutton's Co-Investors

Tom HuttonTom HuttonCo-invested · MoCaFi Series A

Wende Hutton's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Wende Hutton

Rich BoyleRich BoyleBoard Member · ZiboLaura ChauLaura ChauBoard Member · OllieColleen CuffaroColleen CuffaroBoard Member · New England Venture Capital AssociationRayfe Gaspar-AsaokaRayfe Gaspar-AsaokaBoard Member · Fireflies.aiMichael GilroyMichael GilroyBoard Member · StepBob MigliorinoBob MigliorinoBoard Member · Mzinga